Compare PALI & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PALI | ASLE |
|---|---|---|
| Founded | 1996 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 311.8M | 335.5M |
| IPO Year | N/A | N/A |
| Metric | PALI | ASLE |
|---|---|---|
| Price | $1.92 | $7.40 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $17.67 | $7.00 |
| AVG Volume (30 Days) | ★ 5.8M | 306.2K |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $339,090,000.00 |
| Revenue This Year | N/A | $1.35 |
| Revenue Next Year | N/A | $19.09 |
| P/E Ratio | ★ N/A | $66.41 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.53 | $5.56 |
| 52 Week High | $2.64 | $9.12 |
| Indicator | PALI | ASLE |
|---|---|---|
| Relative Strength Index (RSI) | 47.33 | 67.64 |
| Support Level | $2.24 | $7.02 |
| Resistance Level | $2.55 | $7.54 |
| Average True Range (ATR) | 0.20 | 0.18 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 31.82 | 78.08 |
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.